Merck has built on its two decades of support for people living with Multiple Sclerosis by contributing more than any other organisation in The May 50K to support vital research.
Merck’s record support for the Australian Multiple Sclerosis Community
July 5, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
The 'Week in Review' - 24 January
January 24, 2025 - - Podcast -
Cabinet documents reveal decades-old focus on faster PBS listings
January 24, 2025 - - Latest News -
No probity advisor but what about a form of confidentiality deed?
January 24, 2025 - - Latest News -
CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines
January 23, 2025 - - Latest News -
New preventive treatments could support ongoing fight against COVID
January 23, 2025 - - Latest News -
Pharmac encourages input on on multiple medicines funding proposal
January 22, 2025 - - Latest News -
Immutep completes patient enrolment for EFTISARC-NEO Phase 2 trial
January 22, 2025 - - Australian Biotech